Cannabis Use and its Association with Psychological Disorders.
Urits I, Gress K, Charipova K, Li N, Berger AA, Cornett EM, Hasoon J, Kassem H, Kaye AD, Viswanath O.
Psychopharmacol Bull. 2020 May 19;50(2):56-67.
Proceedings of the 3rd IPLeiria's International Health Congress : Leiria, Portugal. 6-7 May 2016.
Tomás CC, Oliveira E, Sousa D, Uba-Chupel M, Furtado G, Rocha C, Teixeira A, Ferreira P, Alves C, Gisin S, Catarino E, Carvalho N, Coucelo T, Bonfim L, Silva C, Franco D, González JA, Jardim HG, Silva R, Baixinho CL, Presado MªH, Marques MªF, Cardoso ME, Cunha M, Mendes J, Xavier A, Galhardo A, Couto M, Frade JG, Nunes C, Mesquita JR, Nascimento MS, Gonçalves G, Castro C, Mártires A, Monteiro MªJ, Rainho C, Caballero FP, Monago FM, Guerrero JT, Monago RM, Trigo AP, Gutierrez ML, Milanés GM, Reina MG, Villanueva AG, Piñero AS, Aliseda IR, Ramirez FB, Ribeiro A, Quelhas A, Manso C, Caballero FP, Guerrero JT, Monago FM, Santos RB, Jimenez NR, Nuñez CG, Gomez IR, Fernandez MªJL, Marquez LA, Moreno AL, Huertas MªJT, Ramirez FB, Seabra D, Salvador MªC, Braga L, Parreira P, Salgueiro-Oliveira A, Arreguy-Sena C, Oliveira BF, Henriques MªA, Santos J, Lebre S, Marques A, Festas C, Rodrigues S, Ribeiro A, Lumini J, Figueiredo AG, Hernandez-Martinez FJ, Campi L, Quintana-Montesdeoca MªP, Jimenez-Diaz JF, Rodriguez-De-Vera BC, Parente A, Mata MªA, Pereira AMª, Fernandes A, Brás M, Pinto MªR, Parreira P, Basto ML, Rei AC, Mónico LM, Sousa G, Morna C, Freitas O, Freitas G, Jardim A, Vasconcelos …
BMC Health Serv Res. 2016 Jul 6;16 Suppl 3(Suppl 3):200. doi: 10.1186/s12913-016-1423-5.
Role of cannabinoids in alcohol-induced neuroinflammation.
García-Baos A, Alegre-Zurano L, Cantacorps L, Martín-Sánchez A, Valverde O.
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jan 10;104:110054. doi: 10.1016/j.pnpbp.2020.110054. Epub 2020 Aug 3.
Responding to illicit drug use in family practice.
Robertson JR, Robertson AR.
Curr Opin Psychiatry. 2015 Jul;28(4):286-91. doi: 10.1097/YCO.0000000000000174.
Alcohol and other drug use among Belgian workers and job-related consequences.
Lambrechts MC, Vandersmissen L, Godderis L.
Occup Environ Med. 2019 Sep;76(9):652-659. doi: 10.1136/oemed-2019-105690.
Delphi method applicability in drug foresight.
Lintonen T, Karjalainen K, Rönkä S, Kotovirta E, Niemelä S.
Subst Abuse Treat Prev Policy. 2024 Jul 27;19(1):35. doi: 10.1186/s13011-024-00617-7.
Determinants of mental health and abuse of psychoactive substances associated with tobacco use. A case-control study.
Amorim TA, Lucchese R, Silva Neta EMD, Santos JSD, Vera I, Paula NI, Simões ND, Monteiro LHB.
Cien Saude Colet. 2019 Oct 28;24(11):4141-4152. doi: 10.1590/1413-812320182411.02752018. eCollection 2019.
Serotonin receptors as potential targets for modulation of nicotine use and dependence.
Fletcher PJ, Lê AD, Higgins GA.
Prog Brain Res. 2008;172:361-83. doi: 10.1016/S0079-6123(08)00918-7.
Changes in medical use of central nervous system stimulants among US adults, 2013 and 2018: a cross-sectional study.
Moore TJ, Wirtz PW, Kruszewski SP, Alexander GC.
BMJ Open. 2021 Aug 13;11(8):e048528. doi: 10.1136/bmjopen-2020-048528.
"Go Ask Alice": The Case for Researching Schedule I Drugs.
Iserson KV.
Camb Q Healthc Ethics. 2019 Jan;28(1):168-177. doi: 10.1017/S0963180118000518.
